ZOLADEX LA

Google image searchProduct monograph

Active ingredient

goserelin (goserelin acetate), 10.8 MG

DIN: 02225905

Dosage form(s): IMPLANT

Route(s) of administration: SUBCUTANEOUS

Schedule: Prescription

Company: TERSERA THERAPEUTICS LLC

Date: 28-FEB-2018

ATC:

Reference brand drug: Goserelin

Search on Google